Federated Hermes’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $126K | Hold |
3,500
| – | – | ﹤0.01% | 1561 |
|
2025
Q1 | $109K | Sell |
3,500
-3,500
| -50% | -$109K | ﹤0.01% | 1576 |
|
2024
Q4 | $179K | Hold |
7,000
| – | – | ﹤0.01% | 1497 |
|
2024
Q3 | $198K | Hold |
7,000
| – | – | ﹤0.01% | 1484 |
|
2024
Q2 | $185K | Sell |
7,000
-2,000
| -22% | -$52.7K | ﹤0.01% | 1493 |
|
2024
Q1 | $273K | Sell |
9,000
-3,000
| -25% | -$91.1K | ﹤0.01% | 1436 |
|
2023
Q4 | $337K | Sell |
12,000
-8,000
| -40% | -$225K | ﹤0.01% | 1428 |
|
2023
Q3 | $543K | Buy |
20,000
+8,000
| +67% | +$217K | ﹤0.01% | 1306 |
|
2023
Q2 | $369K | Hold |
12,000
| – | – | ﹤0.01% | 1457 |
|
2023
Q1 | $432K | Hold |
12,000
| – | – | ﹤0.01% | 1445 |
|
2022
Q4 | $474K | Buy |
+12,000
| New | +$474K | ﹤0.01% | 1381 |
|
2021
Q1 | – | Sell |
-7,822
| Closed | -$391K | – | 2333 |
|
2020
Q4 | $391K | Buy |
+7,822
| New | +$391K | ﹤0.01% | 1582 |
|